A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX in Subjects 60 Years of Age or Older.
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 10 May 2012 Additional locations (Germany, Spain and United Kingdom) added as reported by European Clinical Trials Database record.
- 13 May 2010 Results were presented at the Annual Scientific Meeting of the American Geriatrics Society (2010).
- 03 Feb 2010 Actual patient number (11999) added as reported by ClinicalTrials.gov.